These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 25315519)

  • 1. Identification of plant-derived natural products as potential inhibitors of the Mycobacterium tuberculosis proteasome.
    Zheng Y; Jiang X; Gao F; Song J; Sun J; Wang L; Sun X; Lu Z; Zhang H
    BMC Complement Altern Med; 2014 Oct; 14():400. PubMed ID: 25315519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Establishment of a Mycobacterium tuberculosis proteasome inhibitor model in vitro].
    Song JX; Jiang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):363-6. PubMed ID: 24047812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vivo Inhibition of Proteasome Activity and Tumour Growth by Murraya koenigii Leaf Extract in Breast Cancer Xenografts and by Its Active Flavonoids in Breast Cancer Cells.
    Noolu B; Gogulothu R; Bhat M; Qadri SS; Reddy VS; Reddy GB; Ismail A
    Anticancer Agents Med Chem; 2016; 16(12):1605-1614. PubMed ID: 27198988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrocyclic Peptides that Selectively Inhibit the
    Zhang H; Hsu HC; Kahne SC; Hara R; Zhan W; Jiang X; Burns-Huang K; Ouellette T; Imaeda T; Okamoto R; Kawasaki M; Michino M; Wong TT; Toita A; Yukawa T; Moraca F; Vendome J; Saha P; Sato K; Aso K; Ginn J; Meinke PT; Foley M; Nathan CF; Darwin KH; Li H; Lin G
    J Med Chem; 2021 May; 64(9):6262-6272. PubMed ID: 33949190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A luminescence assay for natural product inhibitors of the Mycobacterium tuberculosis proteasome.
    Gunderwala A; Porter J
    Phytochem Anal; 2016; 27(2):126-32. PubMed ID: 26778282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational Design of Selective and Bioactive Inhibitors of the Mycobacterium tuberculosis Proteasome.
    Totaro KA; Barthelme D; Simpson PT; Jiang X; Lin G; Nathan CF; Sauer RT; Sello JK
    ACS Infect Dis; 2017 Feb; 3(2):176-181. PubMed ID: 28183185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural Basis for the Species-Selective Binding of N,C-Capped Dipeptides to the Mycobacterium tuberculosis Proteasome.
    Hsu HC; Singh PK; Fan H; Wang R; Sukenick G; Nathan C; Lin G; Li H
    Biochemistry; 2017 Jan; 56(1):324-333. PubMed ID: 27976853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and Mechanistic Study of
    Li C; Liu S; Dong B; Li C; Jian L; He J; Zeng J; Zhou Q; Jia D; Luo Y; Sun Q
    J Med Chem; 2022 Aug; 65(16):11058-11065. PubMed ID: 35926511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fellutamide B is a potent inhibitor of the Mycobacterium tuberculosis proteasome.
    Lin G; Li D; Chidawanyika T; Nathan C; Li H
    Arch Biochem Biophys; 2010 Sep; 501(2):214-20. PubMed ID: 20558127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mycobacterium tuberculosis prcBA genes encode a gated proteasome with broad oligopeptide specificity.
    Lin G; Hu G; Tsu C; Kunes YZ; Li H; Dick L; Parsons T; Li P; Chen Z; Zwickl P; Weich N; Nathan C
    Mol Microbiol; 2006 Mar; 59(5):1405-16. PubMed ID: 16468985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective Phenylimidazole-Based Inhibitors of the
    Zhan W; Hsu HC; Morgan T; Ouellette T; Burns-Huang K; Hara R; Wright AG; Imaeda T; Okamoto R; Sato K; Michino M; Ramjee M; Aso K; Meinke PT; Foley M; Nathan CF; Li H; Lin G
    J Med Chem; 2019 Oct; 62(20):9246-9253. PubMed ID: 31560200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Hydroxy Groups in the A-Ring on the Anti-proteasome Activity of Flavone.
    Nakamura K; Yang JH; Sato E; Miura N; Wu YX
    Biol Pharm Bull; 2015; 38(6):935-40. PubMed ID: 25810454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of New
    Almeleebia TM; Shahrani MA; Alshahrani MY; Ahmad I; Alkahtani AM; Alam MJ; Kausar MA; Saeed A; Saeed M; Iram S
    Molecules; 2021 Apr; 26(8):. PubMed ID: 33923734
    [No Abstract]   [Full Text] [Related]  

  • 14. Discovery of new
    Mehra R; Chib R; Munagala G; Yempalla KR; Khan IA; Singh PP; Khan FG; Nargotra A
    Mol Divers; 2015 Nov; 19(4):1003-19. PubMed ID: 26232029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards Selective Mycobacterial ClpP1P2 Inhibitors with Reduced Activity against the Human Proteasome.
    Moreira W; Santhanakrishnan S; Ngan GJY; Low CB; Sangthongpitag K; Poulsen A; Dymock BW; Dick T
    Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28193668
    [No Abstract]   [Full Text] [Related]  

  • 16. Structure of the Mycobacterium tuberculosis proteasome and mechanism of inhibition by a peptidyl boronate.
    Hu G; Lin G; Wang M; Dick L; Xu RM; Nathan C; Li H
    Mol Microbiol; 2006 Mar; 59(5):1417-28. PubMed ID: 16468986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicity.
    Neilsen PM; Pehere AD; Pishas KI; Callen DF; Abell AD
    ACS Chem Biol; 2013 Feb; 8(2):353-9. PubMed ID: 23190346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of flavonoids on 26S proteasome activity.
    Chang TL
    J Agric Food Chem; 2009 Oct; 57(20):9706-15. PubMed ID: 19795881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoralen Derivatives as Inhibitors of
    Rožman K; Alexander EM; Ogorevc E; Bozovičar K; Sosič I; Aldrich CC; Gobec S
    Molecules; 2020 Mar; 25(6):. PubMed ID: 32178473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pup-proteasome system of Mycobacterium tuberculosis.
    Samanovic MI; Li H; Darwin KH
    Subcell Biochem; 2013; 66():267-95. PubMed ID: 23479444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.